GRP
MRNA icon

Global Retirement Partners’s Moderna MRNA Stock Holding History

Global Retirement Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$85.3K Buy
2,893
+17
+0.6% +$462 ﹤0.01% 2007
2025
Q3 		$74.3K Buy
2,876
+1,107
+63% +$30.9K ﹤0.01% 1679
2025
Q2 		$48.8K Buy
+1,769
New +$46.6K ﹤0.01% 1785
2024
Q4 		$97K Sell
2,334
-292
-11% -$14K ﹤0.01% 1284
2024
Q3 		$175K Sell
2,626
-1,684
-39% -$155K 0.01% 968
2024
Q2 		$512K Sell
4,310
-1,845
-30% -$233K 0.02% 607
2024
Q1 		$656K Buy
6,155
+2,971
+93% +$299K 0.02% 463
2023
Q4 		$325K Buy
3,184
+327
+11% +$27.5K 0.01% 586
2023
Q3 		$298K Buy
2,857
+90
+3% +$10K 0.02% 550
2023
Q2 		$336K Sell
2,767
-2
-0.1% -$267 0.02% 535
2023
Q1 		$360K Buy
2,769
+80
+3% +$13.2K 0.02% 501
2022
Q4 		$483K Buy
2,689
+559
+26% +$91.4K 0.03% 377
2022
Q3 		$320K Buy
2,130
+213
+11% +$32.3K 0.02% 448
2022
Q2 		$274K Sell
1,917
-13
-0.7% -$1.86K 0.02% 491
2022
Q1 		$255K Buy
+1,930
New +$325K 0.02% 502
2021
Q4 		– Sell
-865
Closed -$333K – 1209
2021
Q3 		$333K Buy
865
+565
+188% +$208K 0.03% 372
2021
Q2 		$70K Buy
300
+21
+8% +$3.75K 0.01% 740
2021
Q1 		$37K Sell
279
-116
-29% -$16.8K ﹤0.01% 898
2020
Q4 		$41K Sell
395
-82
-17% -$8.3K 0.01% 797
2020
Q3 		$34K Buy
477
+60
+14% +$4.18K 0.01% 743
2020
Q2 		$27K Sell
417
-723
-63% -$39.6K ﹤0.01% 808
2020
Q1 		$34K Buy
+1,140
New +$26.2K 0.01% 659
2019
Q3 		– Sell
-850
Closed -$12K – 1658
2019
Q2 		$12K Hold
850
– – ﹤0.01% 1063
2019
Q1 		$17K Buy
+850
New +$15.8K ﹤0.01% 884

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Global Retirement Partners's MRNA Position: Q4 2025 in Review

Global Retirement Partners increased its Moderna (MRNA) stake by 0.59% in Q4 2025, buying an estimated $462 and bringing the position to 2,893 shares worth $85.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2007.

Global Retirement Partners first reported a position in MRNA in Q1 2019 and has held it in 24 quarters since. The position peaked at $656K in Q1 2024. 672 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Global Retirement Partners held 2,893 shares of Moderna worth $85.3K as of Q4 2025.
  • Global Retirement Partners bought 17 Moderna shares in Q4 2025, an estimated $462.
  • Moderna made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #2007 holding.
  • Global Retirement Partners first reported a position in Moderna in Q1 2019 and has held it in 24 quarters since.
  • Global Retirement Partners's Moderna position peaked at $656K in Q1 2024.
  • 672 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.